ASX - By Stock
|
IXC |
Re:
Questions to ask Tom in relation to recent announcement dated 27.09.2021
|
|
TheDerivative
|
98 |
16K |
1 |
29/09/21 |
29/09/21 |
ASX - By Stock
|
98
|
16K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Investor Call and Presentation
|
|
TheDerivative
|
154 |
21K |
7 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
154
|
21K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
TheDerivative
|
50 |
8.9K |
8 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
50
|
8.9K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
TheDerivative
|
50 |
8.9K |
4 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
50
|
8.9K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Appendix 4E and Annual Report
|
|
TheDerivative
|
121 |
19K |
3 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
121
|
19K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Potential Invex Valuation
|
|
TheDerivative
|
48 |
11K |
1 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
48
|
11K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Potential Invex Valuation
|
|
TheDerivative
|
48 |
11K |
2 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
48
|
11K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
0 |
03/07/21 |
03/07/21 |
ASX - By Stock
|
53
|
14K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
TheDerivative
|
66 |
16K |
0 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
66
|
16K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
TheDerivative
|
66 |
16K |
1 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
66
|
16K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
1 |
13/06/21 |
13/06/21 |
ASX - By Stock
|
53
|
14K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
0 |
13/06/21 |
13/06/21 |
ASX - By Stock
|
53
|
14K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
4 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
53
|
14K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
1 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
53
|
14K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
2 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
53
|
14K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
2 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
53
|
14K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
4 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
53
|
14K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
TheDerivative
|
53 |
14K |
2 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
53
|
14K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
1 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
133
|
31K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
1 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
133
|
31K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
1 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
133
|
31K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
4 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
133
|
31K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
0 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
0 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Trading Halt
|
|
TheDerivative
|
41 |
9.6K |
2 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
41
|
9.6K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
0 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
1 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
133
|
31K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
0 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
0 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
TheDerivative
|
133 |
31K |
1 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
133
|
31K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
TheDerivative
|
24K |
12M |
14 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
24K
|
12M
|
14
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Chairman's Address to Shareholders
|
|
TheDerivative
|
5 |
2.1K |
1 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
5
|
2.1K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
|
|
TheDerivative
|
61 |
16K |
0 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
61
|
16K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
|
|
TheDerivative
|
61 |
16K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
61
|
16K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
|
|
TheDerivative
|
61 |
16K |
3 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
61
|
16K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
61 |
11K |
0 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
61
|
11K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
61 |
11K |
0 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
61
|
11K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
61 |
11K |
3 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
61
|
11K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
61 |
11K |
2 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
61
|
11K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
61 |
11K |
2 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
61
|
11K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
61 |
11K |
6 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
61
|
11K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
1 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
31
|
5.4K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
2 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
31
|
5.4K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
0 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
31
|
5.4K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
0 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
31
|
5.4K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
1 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
31
|
5.4K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
4 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
31
|
5.4K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
1 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
31
|
5.4K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Postcard to Shareholders
|
|
TheDerivative
|
31 |
5.4K |
0 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
31
|
5.4K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
47 |
12K |
2 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
47
|
12K
|
2
|
|